Abbott Laboratories 

$87.17
4108
-$0.37-0.42% Tuesday 20:00

Statistics

Day High
87.83
Day Low
86.16
52W High
138.08
52W Low
87.17
Volume
17,115,742
Avg. Volume
-
Mkt Cap
151.47B
P/E Ratio
25.06
Dividend Yield
2.89%
Dividend
2.52

Upcoming

Dividends

2.89%Dividend Yield
May 26
$0.63
Feb 26
$0.63
Nov 25
$0.59
Aug 25
$0.59
May 25
$0.59
10Y Growth
9.25%
5Y Growth
6.96%
3Y Growth
7.3%
1Y Growth
6.78%

Earnings

16JulExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Next
1.07
1.21
1.36
1.5
Expected EPS
1.280724
Actual EPS
N/A

Financials

14.72%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
88.66BRevenue
13.05BNet Income

Analyst Ratings

124.67Average Price Target
The highest estimate is 143.00.
From 12 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ABT. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Johnson & Johnson
JNJ
Mkt Cap546.9B
Johnson & Johnson competes with Abbott in multiple segments including medical devices, diagnostics, and pharmaceuticals, making it a direct competitor across several of Abbott's business lines.
Medtronic
MDT
Mkt Cap102.71B
Medtronic competes with Abbott in the medical devices sector, particularly in cardiovascular and diabetes care products.
Thermo Fisher Scientific
TMO
Mkt Cap174.37B
Thermo Fisher Scientific competes with Abbott in the diagnostics and life sciences sector, offering a range of analytical instruments, reagents, and consumables.
Danaher
DHR
Mkt Cap123.97B
Danaher Corporation competes with Abbott in the diagnostics and life sciences industry, particularly through its subsidiary Cepheid, which offers molecular diagnostics solutions.
Boston Scientific
BSX
Mkt Cap83.97B
Boston Scientific competes with Abbott in the medical devices sector, especially in cardiovascular products.
Baxter International
BAX
Mkt Cap8.88B
Baxter International competes with Abbott in the medical devices and nutrition sectors, offering products for critical care, nutrition, renal care, and more.
Stryker
SYK
Mkt Cap112.88B
Stryker competes with Abbott in the medical devices sector, particularly in orthopedics, which indirectly competes with Abbott's offerings in other medical device categories.
Becton Dickinson
BDX
Mkt Cap42.47B
Becton, Dickinson and Company competes with Abbott in the medical technology sector, offering devices, laboratory equipment, and diagnostic products.
Resmed
RMD
Mkt Cap29.87B
ResMed competes with Abbott in the health sector by providing medical devices for sleep disorders and respiratory conditions, which complements Abbott's broader medical device portfolio.
Hologic
HOLX
Mkt Cap16.97B
Hologic competes with Abbott in the diagnostics sector, particularly in women's health, where both companies offer a range of diagnostic and medical imaging solutions.

About

There is no Profile data available for ABL.SG.
Show more...
CEO
Mr. Robert B. Ford
Employees
114000
Country
United States
ISIN
US0028241000

Listings

0 Comments

Share your thoughts

FAQ

What is Abbott Laboratories stock price today?
The current price of ABT is $87.17 USD — it has decreased by -0.42% in the past 24 hours. Watch Abbott Laboratories stock price performance more closely on the chart.
What is Abbott Laboratories stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Abbott Laboratories stocks are traded under the ticker ABT.
Is Abbott Laboratories stock price growing?
ABT stock has fallen by -4.55% compared to the previous week, the month change is a -14.79% fall, over the last year Abbott Laboratories has showed a -34.49% decrease.
What is Abbott Laboratories market cap?
Today Abbott Laboratories has the market capitalization of 151.47B
When is the next Abbott Laboratories earnings date?
Abbott Laboratories is going to release the next earnings report on July 16, 2026.
What were Abbott Laboratories earnings last quarter?
ABT earnings for the last quarter are 1.15 USD per share, whereas the estimation was 1.14 USD resulting in a +0.47% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Abbott Laboratories revenue for the last year?
Abbott Laboratories revenue for the last year amounts to 88.66B USD.
What is Abbott Laboratories net income for the last year?
ABT net income for the last year is 13.05B USD.
Does Abbott Laboratories pay dividends?
Yes, ABT dividends are paid quarterly. The last dividend per share was 0.63 USD. As of today, Dividend Yield (FWD)% is 2.89%.
How many employees does Abbott Laboratories have?
As of May 06, 2026, the company has 114,000 employees.
In which sector is Abbott Laboratories located?
Abbott Laboratories operates in the Health & Wellness sector.
When did Abbott Laboratories complete a stock split?
The last stock split for Abbott Laboratories was on June 01, 1998 with a ratio of 2:1.
Where is Abbott Laboratories headquartered?
Abbott Laboratories is headquartered in Abbott Park, United States.